Dow Jones on track for one of the biggest 1-day point gains ever after vaccine news

The stock market soared on Monday as Pfizer unveiled surprisingly positive news that its COVID-19 vaccine candidate appears to be far more effective than anticipated.
The Dow Jones Industrial Average on Monday climbed over 1,000 points after Pfizer said that an interim analysis showed that the COVID-19 vaccine it's developing is over 90 percent effective, CNN reports.
"At this rate, the Dow is on pace for one of its best days of the year and one of its biggest daily point gains in history," CNN writes.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Dow also set "its first intraday record since February," prior to when markets crashed in March as the coronavirus pandemic hit the U.S., The Wall Street Journal reports. "Cruise operators, airlines and mall owners were also among the market's biggest winners," The Associated Press writes. Experts have noted, though, that it will be months into 2021 before any coronavirus vaccine could become widely available in the United States if it's ultimately approved by the Food and Drug Administration.
The stock market's surge also came after on Saturday, former Vice President Joe Biden officially became president-elect, as news outlets called the 2020 presidential race in his favor.
"We all sort of knew that November would be a pretty important period for last stage news on the three main vaccines," NatWest Markets strategist James McCormick told The Wall Street Journal. "The news is clearly pretty positive. We've got the election past us and now the market is focusing on what’s next."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Marbled tea eggs recipe
The Week Recommends With a beautiful exterior, these eggs are also marked by their soft yolk
By The Week UK Published
-
The Washington Post: kowtowing to Trump?
Talking Point The newspaper's opinion editor has handed in his notice following edict from Jeff Bezos
By The Week UK Published
-
Gene Hackman: the death of a Hollywood legend
The French Connection actor had an extraordinary gift for making characters believable
By The Week UK Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published